NEW YORK (TheStreet.com) -- CHANGE IN RATINGS
Caseys General Stores
United Rentals Upgraded to Buy at UBS on Biden Infrastructure Plan
Joe Biden's infrastructure plan would lead to a 'faster-than-expected recovery' in United Rentals’ business, UBS said, upgrading the stock.
upgraded at Barclays to Overweight from Equal Weight on solid business model and strong long-term growth prospects. Price target increased to $38 from $30. 2010 EPS estimate set at $2.45.
upgraded at Credit Suisse to Outperform from Neutral on expanding emerging markets, rebound in NA machinery. Price target surged to $63 from $40. 2009 and 2010 EPS estimates set at $1.43 and $1.95, respectively.
upgraded at Bank of America/Merrill Lynch upgraded CLMS to Buy from Underperform on valuation.
downgraded at JP Morgan to Neutral. Stock may have peaked in the near term, ahead of earnings.
downgraded at Stephens from Overweight to Equal-weight. $13 price target. Supply should continue to increase for the next couple of years, which will keep rates weak.
upgraded at UBS from Neutral to Buy. $77 price target. Risk has been reduced for the Partner trial.
( FMCN) upgraded at Susquehanna from Neutral to Positive. $13 price target. CEO has taken a larger stake in the company, which is cutting costs to boost free cash flow.
upgraded at Goldman from Sell to Neutral. Valuation call, as the company has attractive holdings.
( HOC) upgraded at Goldman from Neutral to Buy. Likely moving through the trough of the refining cycle right now.
upgraded at Merrill/BofA to Buy from Neutral. Should investors rotate to US equity a some point, we think Janus could benefit given their strong performance this year, said analysts.
downgraded at Merrill/BofA to Underperform from Neutral as shares have risen 22% and reached above $28 price target. It will take time to garner new sales, said Bank of America/Merrill Lynch.
( MEE) downgraded at JP Morgan to Neutral. Valuation call, ahead of the upcoming earnings season.
( MFE) upgraded at FBR from Market Perform to Outperform. $50 price target. Field checks have shown an uptick in business over the past few weeks.
downgraded at Oppenheimer to Underperform. Partnership may be delayed and the FDA may require more studies for the company's inhalers.
upgraded at Goldman to Buy. Company has leverage to oil and the stock should continue to Outperform.
Procter & Gamble
rated new Buy at Jefferies. $70 price target. New CEO should help drive outperformance.
( RIMM) upgraded at Credit Suisse to Outperform from Neutral on rebounding industry activity. Price target lifted to $64 from $49. 2010 and 2011 EPS estimates changed to $1.65 from $1.50 and to $3.06 from $3.25.
Resources Global Professionals
( RIMM) upgraded at Credit Suisse to Outperform from Neutral on attractive risk-reward given recent underperformance. Price target raised to $22 from $16. 2009 EPS estimate set at $0.52 while 2010 is lowered to $0.10 from $0.15.
Research in Motion
( RIMM) downgraded at Goldman from Conviction Buy to Neutral. Estimates also cut, as new products have failed to drive significant growth. $73 price target.
Research In Motion
( RIMM) price target cut at Barclays to $90 from $100. 2010 and 2011 EPS estimates set at $4.15 and $4.99, respectively. Maintain Overweight rating.
Research in Motion
( RIMM) numbers cut at UBS to $84. Estimates also lowered, to reflect lower sales momentum. Neutral rating.
downgraded at Goldman from Neutral to Sell. Valuation call.
upgraded at Goldman from Sell to Neutral. Expect to see a gradual recovery in the refining market.
upgraded at Credit Suisse to Outperform from Neutral as TEX offers the most long-term potential upside on a global economic recovery, said Credit Suisse. Price target nearly doubled to $31 from $16. 2009 EPS set at -$1.44 and 2010 lifted to $0.34 from -$0.25.
STOCK COMMENTS / EPS CHANGES
price target up at Credit Suisse to $62 from $49 on better margin performance. 2009 EPS estimate set at $1.42 and 2010 lifted to $2.25 from $1.80. Reiterate Outperform rating.
cut from Conviction Sell list at Goldman. $45 price target. Healthcare reform risk is improving.
price target, estimate raised at Credit Suisse to $59 from $49. 2011 EPS estimate increased to $3.65 from $3.60. Maintain 2009 and 2010 EPS estimate at $1.72 and $2.40. Neutral rating.
price target lowered at Merrill/BofA to $29 from $32. Maintain Neutral rating.
price target dropped at Merrill/BofA to $33 from $35 to reflect lower estimates. Maintain Buy rating.
price target surges at Barclays to $575 from $495 as the company should produce better than expected results over the next few quarters. 2009 and 2010 EPS estimates increased to $22.11 and $25.86, respectively. Overweight rating.
target boosted at Goldman to $56. Company should be able to continue to grow margins. Buy rating.
price target higher at Barclays to $57 from $50. 2009 and 2010 EPS estimates maintained at $3.82 and $4.30, respectively. Reiterate Overweight rating.
Philip Morris Int'l.
estimates raised at Morgan Stanley through 2011. Weaker dollar should help earnings. Overweight rating and $54 price target.
price target increased at Credit Suisse to $1.50 from $1.00. 2010 and 2011 EPS estimates lowered to -$0.57 and -$0.29, respectively. Neutral rating.
estimates lowered at UBS through 2011. Company is realizing lower gross margins and same-store sales should remain negative. Buy rating and $4.
numbers increased at FBR to $19. Estimates also boosted, to reflect improving sales trends. Outperform rating.
estimates, target raised at FBR. Shares now seen reaching $9. Estimates also boosted, to reflect improving operating momentum. Market Perform rating.
target boosted at Citigroup to $40. Company looks attractive, based on a sum-of-the-parts valuation. Buy rating.
estimates, target boosted at UBS. Shares now seen reaching $44. Estimates also raised, to reflect an eventual increase in volume. Neutral rating.
target boosted at Citigroup to $82. The industry still has room to run, despite recent gains. Buy rating.
estimates lowered at Morgan Stanley through 2011. Company is seeing lower wireline margins and fewer new FiOS and data subscribers. Equal-weight rating.
This article was written by a staff member of TheStreet.com.